CAMTA1 T polymorphism is associated with neuropsychological test performance in older adults with cardiovascular disease

Psychogeriatrics

Volumn 11, Issue 3, 2011, Pages 135-140

  Miller, Lindsay A ^a   Gunstad, John ^a,b   Spitznagel, Mary Beth ^a   Mccaffery, Jeanne ^c   Mcgeary, John ^c,d   Poppas, Athena ^e   Paul, Robert H ^f   Sweet, Lawrence H ^c   Cohen, Ronald A ^c  

^a KENT STATE UNIVERSITY   (United States)

^b SUMMA HEALTH SYSTEM   (United States)

^c BROWN UNIVERSITY   (United States)

^d PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Rhode Island Medical Center   (United States)

^f UNIVERSITY OF MISSOURI ST LOUIS   (United States)

Author keywords

CAMTA1 protein; Cardiovascular disease; Cognition; Genetics; Neuropsychology

Indexed keywords

CALMODULIN BINDING TRANSCRIPTION ACTIVATOR 1; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

AGED; ALLELE; ARTICLE; ATTENTION; ATTENTION EXECUTIVE FUNCTION PSYCHOMOTOR SPEED TEST; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; COGNITION; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HUMAN; LEARNING TEST; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL FUNCTION; MENTAL PERFORMANCE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; SINGLE NUCLEOTIDE POLYMORPHISM; STROOP TEST; THE CALIFORNIA VERBAL LEARNING TEST;

AGED; ALLELES; CALCIUM-BINDING PROTEINS; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; DEMENTIA, VASCULAR; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; LONGITUDINAL STUDIES; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC; REFERENCE VALUES; RISK FACTORS; TRANS-ACTIVATORS;

EID: 80053145526     PISSN: 13463500     EISSN: 14798301     Source Type: Journal    
DOI: 10.1111/j.1479-8301.2011.00357.x     Document Type: Article

References (28)

1. American Heart Association. Heart disease and stroke statistics 2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119: e21-e181.
2. Rosendorf C, Beeri MS, Silverman JM. Cardiovascular risk factors for Alzheimer's disease. Am J Geriatr Cardiol 2007; 16: 143-149.
3. Vogels RLC, Oosterman JM, van Harten B etal. Neuroimaging and correlates of cognitive function among patients with heart failure. Dement Geriatr Cogn Disord 2007; 24: 418-423.
4. Vogels RLC, Weinstein HC, Schroeder-Tanka JM. Cogntive impairment in heart failure: A systematic review of the literature. Eur J Heart Fail 2006; 9: 440-449.
5. Ernest CS, Murphy BM, Worcester MUC etal. Cognitive function in candidates for coronary artery bypass graft surgery. Ann Thorac Surg 2006; 82: 812-818.
6. Jefferson AL, Poppas A, Paul RH, Cohen RA. Systemic hypoperfusion is associated with executive dysfunction in geriatric cardiac patients. Neurobiol Aging 2007; 28: 477-483.
7. Moser DJ, Miller IN, Hoth KF, Correia M, Arndt S, Haynes WG. Vascular smooth muscle function is associated with initiation and processing speed in patients with atherosclerotic vascular disease. J Int Neuropsychol Soc 2008; 14: 535-541.
8. Hoth KF, Tate DF, Poppas A etal. Endothelial function and white matter hyperintensities in older adults with cardiovascular disease. Stroke 2007; 38: 308-312.
9. Jefferson AL, Tate DE, Poppas A etal. Lower cardiac output is associated with greater white matter hyperintensities in older adults with cardiovascular disease. J Am Geriatr Soc 2007; 55: 1044-1048.
10. Cohen RA, Poppas A, Forman DE etal. Vascular and cognitive functions associated with cardiovascular disease in the elderly. J Clin Exp Neuropsychol 2009; 31: 96-110.
11. Longenecker JC, Coresh J, Powe NR etal. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE study. J Am Soc Nephrol 2002; 13: 1918-1927.
12. Roriz-Filho JS, Sá-Roriz TM, Rosset I etal. (Pre)diabetes, brain, aging, and cognition. Biochim Biophys Acta 2009; 1792: 432-443.
13. Kodl CT, Seaquist ER. Cognitive dysfunction and diabetes mellitus. Endocr Rev 2008; 29: 494-511.
14. van den Berg E, Dekker JM, Nijpels G etal. Cognitive functioning in elderly persons with Type 2 diabetes and metabolic syndrome: The Hoorn study. Dement Geriatr Cogn Disord 2008;26: 261-269.
15. Akbaraly TN, Kivimaki M, Shipley MJ etal. Metabolic syndrome over 10years and cognitive functioning in late midlife: The Whitehall II study. Diabetes Care 2010; 33: 84-89.
16. Liu CY, Zhou HD, Xu ZQ, Zhang WW, Li XY, Zhao J. Metabolic syndrome and cognitive impairment amongst elderly people in Chinese population: A cross-sectional study. Eur J Neurol 2009; 16: 1022-1027.
17. Reddy KJ, Singh M, Bangit JR, Batsell RR. The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: An updated review. J Cardiovasc Med (Hagerstown) 2010; 11: 633-647.
18. van den Berg E, Dekker JM, Nijpels G etal. Blood pressure levels in pre-diabetic stages are associated with worse cognitive functioning in patients with Type 2 diabetes. Diabetes Metab Res Rev 2009; 25: 657-664.
19. Cauchi S, Proença C, Choquet H etal. Analysis of novel risk loci for Type 2 diabetes in a general French population: The D.E.S.I.R. study. J Mol Med 2008; 86: 341-348.
20. Sladek R, Rocheleau G, Run J etal. A genone-wide association study identifies novel risk loci for Type 2 diabetes. Nature 2007; 445: 881-885.
21. Huentelman MJ, Papassotiropoulos A, Craig DW etal. Calmodluin-binding transcription activator 1 (CAMTA1) alleles predispose human episodic memory performance. Hum Mol Genet 2007; 16: 1469-1477.
22. Folstein MF, Folstein SE, McHugh RR. 'Mini-Mental State'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
23. Delis D, Kramer J, Kaplan E, Ober B. Manual: California Verbal Learning Test, Adult Version. San Antonio, TX: Psychological Corporation, 1987.
24. Reitan R. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 1958; 8: 271-276.
25. Wechsler D. Manual for the Wechsler Adult Intelligence Scale, 3rd edn. San Antonio, TX: The Psychological Corporation, 1997.
26. Golden JC. Stroop Color Word Test. Chicago, IL: Stoelting, 1978.
27. Livak KJ, Marmaro J, Todd JA. Towards fully automated genome-wide polymorphism screening. Nat Genet 1995; 9: 341-342.
28. Liistro T, Guiducci L, Burchielli S etal. Brain glucose overexposure and lack of acute metabolic flexibility in obesity and Type 2 diabetes: A PET-[(18)F]FDG study in Zucker and ZDF rats. J Cereb Blood Flow Metab 2010; 30: 895-899.